Epicatechin
(-)-Epicatechin
A powerful flavonoid found in dark chocolate that may enhance muscle growth, endurance, and cardiovascular health by inhibiting myostatin.
(-)-Epicatechin is a flavonoid abundant in dark chocolate, cocoa, and green tea. It's gained attention for its potential to enhance muscle growth by inhibiting myostatin (a protein that limits muscle growth) and increasing follistatin. It also supports cardiovascular health through nitric oxide enhancement and improved endothelial function. The muscle-building effects are of particular interest to athletes seeking natural performance enhancement.
Mechanisms of Action
Myostatin Inhibition
Reduces myostatin, a muscle growth limiter
Nitric Oxide Enhancement
Improves blood vessel function
Mitochondrial Biogenesis
Increases mitochondria in muscles
Recommended Dose
100-200mg daily
Loading: Not established
Optimal Timing
- With meals
- Pre-workout or morning
Take with food
Best Form
Pure (-)-Epicatechin extract
Alternatives: High-epicatechin cocoa extract, Dark chocolate (food source)
Isolated epicatechin allows precise dosing. Dark chocolate contains ~50mg per 50g but also has calories/sugar.
Duration
Minimum: 4 weeks
Optimal: 8 weeks
Cycling: 8 weeks on, 4 weeks off; or continuous for cardiovascular benefits
Note: Taking with fat may improve absorption. Can be taken before workouts for potential NO benefits.
Personalized Dosage Calculator
Get a dosage recommendation tailored to your body weight, age, goals, and health profile.
Set up your health profile for personalized recommendations
Muscle Support
Potential enhancement of muscle growth and strength
Cardiovascular Support
Improved blood flow and endothelial function
Endurance Support
Enhanced exercise capacity
Limited Human Data
Most muscle studies are preclinical
Promising for muscle and endurance; more research needed
Who Should NOT Take This
- Known allergy or hypersensitivity to Epicatechin or related compounds
Drug Interactions
Theoretical interaction due to NO effects — may affect platelet aggregation or vitamin K-dependent clotting factors, altering anticoagulant efficacy
Possible Side Effects
Tip: Take with food
Tip: Reduce dose
Warnings
- Human research for muscle effects is limited
- Most myostatin studies are in animals
- Expensive as isolated compound
Top studies from 40+ peer-reviewed papers
Jin H et al. • The Cochrane database of systematic reviews (2012)
“There is insufficient and conflicting evidence regarding flavonoid intake and the prevention of colorectal neoplasms.”
Key Findings:
- A statistically significant reduced risk of CRC was found with high intake of epicatechin.
- There is insufficient and conflicting evidence regarding flavonoid intake and the prevention of colorectal neoplasms.
- It is difficult to determine flavonoid intake.
- Therefore, more evidence is needed to clarify the association between flavonoids and colorectal neoplasms.
Hooper L et al. • The American journal of clinical nutrition (2012)
“We found consistent acute and chronic benefits of chocolate or cocoa on FMD and previously unreported promising effects on insulin and HOMA-IR.”
Key Findings:
- Insulin resistance (HOMA-IR: -0.67; 95% CI: -0.98, -0.36) was improved by chocolate or cocoa due to significant reductions in serum insulin.
- Flow-mediated dilatation (FMD) improved after chronic (1.34%; 95% CI: 1.00%, 1.68%) and acute (3.19%; 95% CI: 2.04%, 4.33%) intakes.
- We found consistent acute and chronic benefits of chocolate or cocoa on FMD and previously unreported promising effects on insulin and HOMA-IR.
- Larger, longer-duration, and independently funded trials are required to confirm the potential cardiovascular benefits of cocoa flavan-3-ols.
Lagou V et al. • European journal of preventive cardiology (2025)
“Flavan-3-ol-rich foods considerably reduce elevated BP and improve endothelial function independent of blood pressure supporting their use for cardiovascular prevention.”
Key Findings:
- Flavan-3-ol interventions included epicatechin, epigallocatechin-gallate, cocoa products, tea, grape extract, and apples delivering 586 mg (95% CI 510, 662) total flavan-3-ols.
- Interventions decreased office (-2.8 [95% CI -3.9, -1.7]/-2.0 [-2.6, -1.3] mmHg) and 24 h-ambulatory BP (-3.7 [-5.8, -1.6]/-2.6 [-4.5, -0.8] mmHg) after chronic repetitive consumption.
- Flow-mediated dilation increased after acute (+2.0% [1.6, 2.3]) and repetitive (+1.7% [1.3, 2.2]) consumption independent of BP.
- Reported adverse events were minor and low (0.4%).
Li Y et al. • Critical reviews in food science and nutrition (2025)
“Further research is needed to enhance biomarker validity for precise dietary intake assessment in epidemiological studies.”
Key Findings:
- The most extensively validated biomarkers, SREM and PgVLM in 24-h urine, met five validation criteria.
- However, challenges remain, including limited specificity, short half-lives, inter-individual variability, and a lack of authentic chemical standards.
- Further research is needed to enhance biomarker validity for precise dietary intake assessment in epidemiological studies.
Christen WG et al. • JAMA ophthalmology (2025)
“In this ancillary study of the COSMOS randomized clinical trial, cocoa extract supplementation for a median period of 3.6 years among older women and men had no effect overall on occurrence of AMD.”
Key Findings:
- Mean (SD) participant age was 72.1 (6.6) years, and 12 666 participants (59.1%) were female.
- During a median (IQR) period of 3.6 (3.2-4.2) years of treatment and follow-up, 344 participants (1.6%) experienced a confirmed AMD event (316 incident AMD, 28 progression to advanced AMD).
- For the primary composite end point, there were 159 cases (1.5%) in the cocoa extract group and 185 cases (1.7%) in the placebo group (hazard ratio [HR], 0.87; 95% CI, 0.71-1.08; P = .21).
Study Type Distribution
Goals This Supplement Supports
Related Goals
This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement.